Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics

Elevated low-density lipoprotein cholesterol (LDL-C) is one of the major contributors to cardiovascular heart disease (CHD), the leading cause of death worldwide. Due to severe side effects of statins, alternative treatment strategies are required for statin-intolerant patients. Monoclonal antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoshnejad, Makan, Patel, Ami, Wojtak, Krzysztof, Kudchodkar, Sagar B., Humeau, Laurent, Lyssenko, Nicholas N., Rader, Daniel J., Muthumani, Kar, Weiner, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319316/
https://www.ncbi.nlm.nih.gov/pubmed/30449662
http://dx.doi.org/10.1016/j.ymthe.2018.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319316/
https://www.ncbi.nlm.nih.gov/pubmed/30449662
http://dx.doi.org/10.1016/j.ymthe.2018.10.016

Ejemplares similares